A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.

NCT03648801 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-08-31

No results posted yet for this study

Summary

Post-marketing surveillance of Telostop Plus Tab.

Conditions

  • Hypertension, Dyslipidemia

Sponsors & Collaborators

  • IlDong Pharmaceutical Co Ltd

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2024-05-31
Completion
2024-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648801 on ClinicalTrials.gov